Optimal Identification and Management of Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a progressive disease and is associated with poor clinical outcomes. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the average length of time from symptom onset to diagnosis estimated to range from 1 to 3 years. This initiative provides an experience that goes beyond the presentation of information, to one that provides an opportunity to discuss priorities with knowledgeable experts and peers, share experiences, and formulate actionable plans to improve the quality of care provided to your patients with PAH.

CME/CE Accreditation Information